Hypertensive Disorders of Pregnancy in Adolescence and Primipaternity
|ClinicalTrials.gov Identifier: NCT01374477|
Recruitment Status : Unknown
Verified January 2015 by Osvaldo A. Reyes T., Saint Thomas Hospital, Panama.
Recruitment status was: Recruiting
First Posted : June 16, 2011
Last Update Posted : January 5, 2015
Hypertensive disorders of pregnancy are one of the most frequent complications of pregnancy, being a serious health problem around the world.
Previous studies have suggested that there is an association between a short period of exposure to paternal sperm of a new sexual partner and the development of an immunological reaction that could trigger a hypertensive disorder of pregnancy. For this reason we want to study the relationship between the primipaternity concept (exposure to male antigens present in semen over a short period of time previous to the pregnancy) and the development of preeclampsia in adolescents.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||110 participants|
|Observational Model:||Case Control|
|Official Title:||Hypertensive Disorders of Pregnancy in Adolescence and the Primipaternity Concept. Cases and Control Trial|
|Study Start Date :||June 2012|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||January 2016|
Adolescent with preeclampsia
Patients < 19 years old who delivered in our institution (vaginal birth or cesarean) that developed a hypertensive disorder of pregnancy.
Patients < 19 years old who delivered in our institution (vaginal birth or cesarean) without developing a hypertensive disorder of pregnancy.
- Presence of a primipaternity factor [ Time Frame: Two months ]
The presence of primipaternity factor. They include:
- Sexual Cohabitation (timeframe between first sexual intercourse and pregnancy < 4 months)without the use of a barrier contraceptive.
- Oral sex with ejaculation (previous to pregnancy < 4 months).
- Maternal complications [ Time Frame: Two months ]Presence of a complication related to preeclampsia: abruptio placenta, HELLP syndrome, eclampsia.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01374477
|Contact: Leisa Rosas, MDfirstname.lastname@example.org|
|Contact: Osvaldo Reyes, MDemail@example.com|
|Saint Thomas Hospital||Recruiting|
|Panama, Panama, 1439 zona 9A|
|Principal Investigator: Leisa Rosas, MD|
|Principal Investigator: Osvaldo Reyes, MD|
|Principal Investigator:||Osvaldo Reyes, MD||Saint Thomas Hospital, Panama|